Angela Koehler appointed faculty director of the Deshpande Center
A biotech entrepreneur, Koehler will help faculty and students launch startups and bring new products to market through the MIT Deshpande Center for Technological Innovation.
A biotech entrepreneur, Koehler will help faculty and students launch startups and bring new products to market through the MIT Deshpande Center for Technological Innovation.
BioAutoMATED, an open-source, automated machine-learning platform, aims to help democratize artificial intelligence for research labs.
The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.
The first RNA-guided DNA-cutting enzyme found in eukaryotes, Fanzor could one day be harnessed to edit DNA more precisely than CRISPR/Cas systems.
SMART researchers combine rifaximin and clarithromycin to effectively restore the latter drug's efficacy.
C16 Biosciences, founded by MIT alumni, has developed a microbial oil to replace palm oil, whose production reaps environmental devastation.
Synthetic biology expert to succeed Angela Belcher as department head effective Aug. 1.
MIT-Novo Nordisk Artificial Intelligence Postdoctoral Fellows Program will support up to 10 postdocs annually over five years.
By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.
Tactile stimulation improved motor performance, reduced phosphorylated tau, preserved neurons and synapses, and reduced DNA damage, a new study shows.
The machine-learning algorithm identified a compound that kills Acinetobacter baumannii, a bacterium that lurks in many hospital settings.
Fifteen principal investigators from across MIT will conduct early work to solve issues ranging from water contamination to aquaculture monitoring and management.
The Fulbright US Student Program funds opportunities for research, graduate study, and teaching abroad.
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.
Matt Shoulders will lead an interdisciplinary team to improve RuBisCO — the photosynthesis enzyme thought to be the holy grail for improving agricultural yield.